( MENAFN - EIN Presswire) Opioid Use Disorder market Report Opioid Use Disorder companies are Trevena, Opiate Pharmaceutical, Aphios, Kyowa kirin, Gamida-Cell, Novartis, and others. LAS VEGAS, NEVADA, UNITED STATES, June 9, 2024 /EINPresswire / -- DelveInsight's“Opioid Use Disorder Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Opioid Use Disorder, historical and forecasted epidemiology as well as the Opioid Use Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Opioid Use Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Opioid Use Disorder Market Forecast Some of the key facts of the Opioid Use Disorder Market Report: The Opioid Use Disorder market size is anticipated to grow with a significant CAGR during the study period (2020-2034).
The Opioid Use Disorder market size in the 7MM was around USD 2,000 million in 2023. The market is anticipated to witness a substantial positive shift owing to better uptake of existing drugs and raised awareness. In 2023, the United States accounted for the largest market size (around USD 1,400 million) of Opioid Use Disorder (OUD), in comparison to EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
Opioid use disorder (OUD) is characterized by chronic opioid use causing distress or impairment, including intense cravings, increased .